Denmark· DK-28103846505
Alfuzosin "Sandoz"
A alfuzosin product containing alfuzosinhydrochlorid, registered in Denmark by Sandoz A/S. The same ATC class is registered in 18 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Alfuzosin is registered in 18 of 19 countries.
Countries holding a registration under ATC G04CA01 (alfuzosin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 11 of them publish a price we can compare per daily dose
Alfuzosin · ATC G04CA01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of alfuzosin costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.25 in France to $0.93 in Switzerland — a ×3.7 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Alfuzosin · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.93
- ES Spain$0.34
- IT Italy$0.25
- FR France$0.25
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- ALFUZOSINHYDROCHLORID
- Manufacturer
- Sandoz A/S
- Country
- Denmark (DK)
- ATC code
- G04CA01
- ATC class
- Alfuzosin
- Defined daily dose
- 7.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103846505
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
330 interactions on record for alfuzosin.
Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alfuzosin · interactions on record
330 records
- 47 severe
- 182 moderate
- 3 minor
- 48 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
50 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G04CA01
Alfuzosin, as other registers publish it.
- PolandAlfabaxRanbaxy (Poland) Sp. z o.o.
- IrelandAlfu 10 mg Prolonged-release TabletsAurobindo Pharma (Malta) Limited
- FinlandAlfuranRanbaxy (UK) Limited
- PolandAlfurionOrion Corporation
- GermanyAlfuzosinAuxilto Healthcare Gmbh
- CanadaALFUZOSINSANIS HEALTH INC
- CanadaALFUZOSINSIVEM PHARMACEUTICALS ULC
- DenmarkAlfuzosin "Orion"Orion Corporation
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/11a5bc85-c9d4-4ef3-b6c6-96986797589d GET /v1/drugs/11a5bc85-c9d4-4ef3-b6c6-96986797589d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "depottabletter",
"source": "dkma",
"strength": "10 mg",
"auth_role": "CMS",
"dk_drugid": "28103846505",
"substance": "ALFUZOSINHYDROCHLORID",
"auth_procedure": "MRP",
"in_medicinpriser": true,
"registration_date_serial": "38761"
}See everything about alfuzosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.